A study to assess incidences of Acute interstitial nephritis after administration of direct-acting antiviral agents in in hepatitis C virus-infected patients
Latest Information Update: 16 Sep 2020
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 16 Sep 2020 New trial record
- 10 Sep 2020 Results published in the Clinical Nephrology